NDC 81647-140-01 - BABLAB SUPER CLEAN CALMING CLEANSING BALM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81647-140
- Requested NDC
- 81647-140-01
- Package NDCs from labels
- 81647-140-01, 81647-140-02
- Manufacturer
- FICC Co., Ltd. | Intercos Korea Inc.
- Effective date
- 2021-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BABLAB SUPER CLEAN CALMING CLEANSING BALM - FICC Co., Ltd. | Intercos Korea Inc. | FICC Co., Ltd. | Intercos Korea Inc. | 2021-06-04 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81647-140-02 | 2023-10-16 | C162847 | 48780-1 | e4f33bdf-af4e-d8a0-e053-dadaa90a6e4e | 7e51dc7f-dbdc-4283-bc3b-20f522bf94aa |
| 81647-140-02 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-af4e-d8a0-e053-dadaa90a6e4e | 7e51dc7f-dbdc-4283-bc3b-20f522bf94aa |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | 8MDF5V39QO |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Vitamex USA, Corp | 5195cab5-bdda-2ddf-e063-6394a90ac9fe | 2026-05-11 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | TWIN MED LLC | 0f867f56-4bc0-4a85-b9d2-a16282b7c82b | 2026-05-01 | Warnings | 8MDF5V39QO |
| Arm and Hammer Baking Soda | SODIUM BICARBONATE | Church & Dwight Co., Inc. | 643fe204-4a7b-00e4-e053-2a91aa0aef06 | 2026-04-21 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr. (650 mg) | SODIUM BICARBONATE | Gendose Pharmaceuticals, LLC | 0a0cc46d-372e-4175-932a-065e82d8d353 | 2026-04-13 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole/Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Proficient Rx LP | 4d642036-7175-4f29-9f07-dbd282231d4a | 2026-04-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Rapidol Sodium Bicarbonate | SODIUM BICARBONATE | Pharmadel LLC | b4c9a653-6f51-7c98-e053-2995a90ada37 | 2026-03-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | bba7d5bf-c94b-4ee4-a399-9a2818d84c78 | 2026-03-23 | Warnings | 8MDF5V39QO |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.